Eddy Freyne

1.1k total citations
25 papers, 491 citations indexed

About

Eddy Freyne is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eddy Freyne has authored 25 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Eddy Freyne's work include Estrogen and related hormone effects (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and Reactions of Organic Compounds (3 papers). Eddy Freyne is often cited by papers focused on Estrogen and related hormone effects (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and Reactions of Organic Compounds (3 papers). Eddy Freyne collaborates with scholars based in Belgium, United States and France. Eddy Freyne's co-authors include Paul A. J. Janssen, Walter Wouters, Fred De Clerck, Didier de Chaffoy de Courcelles, Johan Beetens, R. De Coster, Marc Venet, Jacky Van Dun, Alfons H. M. Raeymaekers and Gérard Sanz and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eddy Freyne

23 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eddy Freyne Belgium 14 195 127 124 74 61 25 491
E. R. WEAVER Malaysia 7 414 2.1× 156 1.2× 83 0.7× 82 1.1× 127 2.1× 8 640
A. A. PATCHETT United States 13 339 1.7× 237 1.9× 44 0.4× 72 1.0× 141 2.3× 25 664
Jason E. Drury United States 13 371 1.9× 64 0.5× 83 0.7× 38 0.5× 22 0.4× 15 755
Nina J. Williams United States 8 531 2.7× 77 0.6× 85 0.7× 84 1.1× 128 2.1× 10 720
Robert L. Rosati United States 10 176 0.9× 137 1.1× 126 1.0× 24 0.3× 12 0.2× 18 395
Lisa Gruber Germany 17 319 1.6× 72 0.6× 116 0.9× 21 0.3× 11 0.2× 21 677
Wen Yan United States 14 316 1.6× 146 1.1× 77 0.6× 16 0.2× 15 0.2× 19 658
Kenji Akahane Japan 10 244 1.3× 181 1.4× 13 0.1× 68 0.9× 71 1.2× 24 555
Vera Lúcia Gonçalves de Moraes Brazil 11 271 1.4× 152 1.2× 68 0.5× 88 1.2× 6 0.1× 13 659
Counde O-Yang United States 13 311 1.6× 266 2.1× 23 0.2× 94 1.3× 16 0.3× 22 649

Countries citing papers authored by Eddy Freyne

Since Specialization
Citations

This map shows the geographic impact of Eddy Freyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy Freyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy Freyne more than expected).

Fields of papers citing papers by Eddy Freyne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddy Freyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy Freyne. The network helps show where Eddy Freyne may publish in the future.

Co-authorship network of co-authors of Eddy Freyne

This figure shows the co-authorship network connecting the top 25 collaborators of Eddy Freyne. A scholar is included among the top collaborators of Eddy Freyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddy Freyne. Eddy Freyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Christopher N., Valério Berdini, Lijs Beke, et al.. (2014). Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase. ACS Medicinal Chemistry Letters. 6(1). 25–30. 25 indexed citations
2.
Perera, Timothy, Jorge Vialard, Tinne Verhulst, et al.. (2014). Abstract 1738: JNJ-42756493 is an inhibitor of FGFR-1, 2, 3 and 4 with nanomolar affinity for targeted therapy. Cancer Research. 74(19_Supplement). 1738–1738. 8 indexed citations
3.
François, Isabelle, Karin Thevissen, Klaartje Pellens, et al.. (2009). Design and Synthesis of a Series of Piperazine‐1‐carboxamidine Derivatives with Antifungal Activity Resulting from Accumulation of Endogenous Reactive Oxygen Species. ChemMedChem. 4(10). 1714–1721. 16 indexed citations
4.
Perera, Tim, Matthias Versele, Philip D. King, et al.. (2006). 588 POSTER JNJ-26483327 is a novel multi-targeted tyrosine kinase inhibitor with cellular activity against EGFR, Her2, Src and VEGFR3. European Journal of Cancer Supplements. 4(12). 178–178. 1 indexed citations
5.
Angibaud, Patrick, Ashis Saha, David W. End, et al.. (2003). 4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™. Bioorganic & Medicinal Chemistry Letters. 13(24). 4361–4364. 13 indexed citations
6.
Angibaud, Patrick, Ann Devine, David W. End, et al.. (2003). 5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(9). 1543–1547. 27 indexed citations
7.
Angibaud, Patrick, David W. End, Eddy Freyne, et al.. (2003). Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(24). 4365–4369. 19 indexed citations
8.
Andrés, José Ignacio, José Manuel Alonso Segura, Javier Fernández, et al.. (2002). Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(4). 653–658. 21 indexed citations
9.
Freyne, Eddy, Alfons H. M. Raeymaekers, Marc Venet, et al.. (1998). Synthesis of LIAZALTM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology. Bioorganic & Medicinal Chemistry Letters. 8(3). 267–272. 17 indexed citations
10.
Freyne, Eddy, et al.. (1992). Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 6–14. 18 indexed citations
11.
Water, A. Van de, Didier de Chaffoy de Courcelles, Eddy Freyne, et al.. (1992). Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.. PubMed. 316. 60–74.
12.
Wouters, Walter, R. De Coster, Jacky Van Dun, et al.. (1990). Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1049–1054. 30 indexed citations
13.
Bruynseels, J., R. De Coster, P. Van Rooy, et al.. (1990). R 75251, a new inhibitor of steroid biosynthesis. The Prostate. 16(4). 345–357. 50 indexed citations
14.
Wouters, Walter, R. De Coster, Jacky Van Dun, et al.. (1989). R 76713, a new specific non-steroidal aromatase inhibitor. Journal of Steroid Biochemistry. 32(6). 781–788. 76 indexed citations
15.
Clerck, Fred De, Johan Beetens, Didier de Chaffoy de Courcelles, Eddy Freyne, & Paul A. J. Janssen. (1989). R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - I. Biochemical Profile In Vitro. Thrombosis and Haemostasis. 61(1). 35–42. 86 indexed citations
16.
Huybrechts, L.M., et al.. (1984). The synthesis of 5-carboxamido-4-hydroxy-3-(β-D-ribofuranosyl)-thiophene derivatives, analogues of pyrazofurin. Tetrahedron. 40(13). 2479–2485. 16 indexed citations
17.
Dommisse, R., et al.. (1983). 13C-NMR Quanternisation Shift Increments for 3-Substituted Pyridines in N-Banzyl- and N-2,4-Dinitrophenyl-pyridinium Salts. Heterocycles. 20(2). 239–239. 2 indexed citations
18.
Alderweireldt, F. C., et al.. (1981). 13C-NMR Shift Increments for 3-Substituted Pyridines. Heterocycles. 16(11). 1893–1893. 4 indexed citations
19.
Freyne, Eddy, et al.. (1980). Stereospecific synthesis of a novel series of pyridine nucleosides. Carbohydrate Research. 78(2). 235–242. 4 indexed citations
20.
Freyne, Eddy, et al.. (1978). Synthesis of a novel β‐NAD+ analogue: 3‐Ac‐5‐Me‐PyrAD+.. Bulletin des Sociétés Chimiques Belges. 87(10). 801–802. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. R. WEAVER Breakdown of academic impact, for papers by A. A. PATCHETT Breakdown of academic impact, for papers by Jason E. Drury Breakdown of academic impact, for papers by Nina J. Williams Breakdown of academic impact, for papers by Robert L. Rosati Breakdown of academic impact, for papers by Lisa Gruber Breakdown of academic impact, for papers by Wen Yan Breakdown of academic impact, for papers by Kenji Akahane Breakdown of academic impact, for papers by Vera Lúcia Gonçalves de Moraes Breakdown of academic impact, for papers by Counde O-Yang
Rankless by CCL
2026